159 related articles for article (PubMed ID: 32464186)
1. Potential of immunotherapies in the mediation of antileukemic responses for patients with acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) - With a focus on Dendritic cells of leukemic origin (DC
Ansprenger C; Amberger DC; Schmetzer HM
Clin Immunol; 2020 Aug; 217():108467. PubMed ID: 32464186
[TBL] [Abstract][Full Text] [Related]
2. Role of Interferon (IFN)α in "Cocktails" for the Generation of (Leukemia-derived) Dendritic Cells (DCleu) From Blasts in Blood From Patients (pts) With Acute Myeloid Leukemia (AML) and the Induction of Antileukemic Reactions.
Hirn Lopez A; Deen D; Fischer Z; Rabe A; Ansprenger C; Stein K; Vogt V; Schick J; Kroell T; Kraemer D; Kolb HJ; Tischer J; Schmid C; Schmetzer H
J Immunother; 2019 Jun; 42(5):143-161. PubMed ID: 31090655
[TBL] [Abstract][Full Text] [Related]
3. Granulocyte-Macrophage-Colony-Stimulating-Factor Combined with Prostaglandin E1 Create Dendritic Cells of Leukemic Origin from AML Patients' Whole Blood and Whole Bone Marrow That Mediate Antileukemic Processes after Mixed Lymphocyte Culture.
Unterfrauner M; Rejeski HA; Hartz A; Bohlscheid S; Baudrexler T; Feng X; Rackl E; Li L; Rank A; Filippini Velázquez G; Schmid C; Schmohl J; Bojko P; Schmetzer H
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139264
[TBL] [Abstract][Full Text] [Related]
4. Serum-free generation and quantification of functionally active Leukemia-derived DC is possible from malignant blasts in acute myeloid leukemia and myelodysplastic syndromes.
Kufner S; Fleischer RP; Kroell T; Schmid C; Zitzelsberger H; Salih H; de Valle F; Treder W; Schmetzer HM
Cancer Immunol Immunother; 2005 Oct; 54(10):953-70. PubMed ID: 15789235
[TBL] [Abstract][Full Text] [Related]
5. Conversion of AML-blasts to leukemia-derived dendritic cells (DCleu) in 'DC-culture-media' shifts correlations of released chemokines with antileukemic T-cell reactions.
Merle M; Fischbacher D; Liepert A; Grabrucker C; Kroell T; Kremser A; Dreyssig J; Freudenreich M; Schuster F; Borkhardt A; Kraemer D; Koehne CH; Kolb HJ; Schmid C; Schmetzer HM
Immunobiology; 2021 May; 226(3):152088. PubMed ID: 33838552
[TBL] [Abstract][Full Text] [Related]
6. Generation of Leukaemia-Derived Dendritic Cells (DC
Schwepcke C; Klauer LK; Deen D; Amberger DC; Fischer Z; Doraneh-Gard F; Gunsilius C; Hirn-Lopez A; Kroell T; Tischer J; Weinmann M; Werner JO; Rank A; Schmid C; Schmetzer HM
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955486
[TBL] [Abstract][Full Text] [Related]
7. PGE
Amberger DC; Doraneh-Gard F; Gunsilius C; Weinmann M; Möbius S; Kugler C; Rogers N; Böck C; Ködel U; Werner JO; Krämer D; Eiz-Vesper B; Rank A; Schmid C; Schmetzer HM
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31533251
[TBL] [Abstract][Full Text] [Related]
8. Dendritic Cells of Leukemic Origin: Specialized Antigen-Presenting Cells as Potential Treatment Tools for Patients with Myeloid Leukemia.
Amberger DC; Schmetzer HM
Transfus Med Hemother; 2020 Dec; 47(6):432-443. PubMed ID: 33442338
[TBL] [Abstract][Full Text] [Related]
9. The quality and quantity of leukemia-derived dendritic cells from patients with acute myeloid leukemia and myelodysplastic syndrome are a predictive factor for the lytic potential of dendritic cells-primed leukemia-specific T cells.
Grabrucker C; Liepert A; Dreyig J; Kremser A; Kroell T; Freudenreich M; Schmid C; Schweiger C; Tischer J; Kolb HJ; Schmetzer H
J Immunother; 2010 Jun; 33(5):523-37. PubMed ID: 20463595
[TBL] [Abstract][Full Text] [Related]
10. Dendritic cells (DCs) can be successfully generated from leukemic blasts in individual patients with AML or MDS: an evaluation of different methods.
Kremser A; Dressig J; Grabrucker C; Liepert A; Kroell T; Scholl N; Schmid C; Tischer J; Kufner S; Salih H; Kolb HJ; Schmetzer H
J Immunother; 2010; 33(2):185-99. PubMed ID: 20139775
[TBL] [Abstract][Full Text] [Related]
11. Antileukemic T-cell responses can be predicted by the composition of specific regulatory T-cell subpopulations.
Schick J; Vogt V; Zerwes M; Kroell T; Kraemer D; Köhne CH; Hausmann A; Buhmann R; Tischer J; Schmetzer H
J Immunother; 2013 May; 36(4):223-37. PubMed ID: 23603857
[TBL] [Abstract][Full Text] [Related]
12. Dendritic Cell-Triggered Immune Activation Goes along with Provision of (Leukemia-Specific) Integrin Beta 7-Expressing Immune Cells and Improved Antileukemic Processes.
Rackl E; Li L; Klauer LK; Ugur S; Pepeldjiyska E; Seidel CL; Gunsilius C; Weinmann M; Doraneh-Gard F; Reiter N; Plett C; Amberger DC; Bojko P; Kraemer D; Schmohl J; Rank A; Schmid C; Schmetzer HM
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613907
[TBL] [Abstract][Full Text] [Related]
13. Quality of T-cells after stimulation with leukemia-derived dendritic cells (DC) from patients with acute myeloid leukemia (AML) or myeloid dysplastic syndrome (MDS) is predictive for their leukemia cytotoxic potential.
Liepert A; Grabrucker C; Kremser A; Dreyssig J; Ansprenger C; Freudenreich M; Kroell T; Reibke R; Tischer J; Schweiger C; Schmid C; Kolb HJ; Schmetzer H
Cell Immunol; 2010; 265(1):23-30. PubMed ID: 20663492
[TBL] [Abstract][Full Text] [Related]
14. Volatile Phases Derived from Serum, DC, or MLC Culture Supernatants to Deduce a VOC-Based Diagnostic Profiling Strategy for Leukemic Diseases.
Baudrexler T; Boeselt T; Li L; Bohlscheid S; Boas U; Schmid C; Rank A; Schmohl J; Koczulla R; Schmetzer HM
Biomolecules; 2023 Jun; 13(6):. PubMed ID: 37371569
[TBL] [Abstract][Full Text] [Related]
15. Leukemia derived dendritic cell (DC
Pepeldjiyska E; Li L; Gao J; Seidel CL; Blasi C; Özkaya E; Schmohl J; Kraemer D; Schmid C; Rank A; Schmetzer HM
Immunobiology; 2022 Jul; 227(4):152237. PubMed ID: 35749805
[TBL] [Abstract][Full Text] [Related]
16. In Vitro Generated Dendritic Cells of Leukemic Origin Predict Response to Allogeneic Stem Cell Transplantation in Patients With AML and MDS.
Freudenreich M; Tischer J; Kroell T; Kremser A; Dreyßig J; Beibl C; Liepert A; Kolb HJ; Schmid C; Schmetzer H
J Immunother; 2022 Feb-Mar 01; 45(2):104-118. PubMed ID: 34864807
[TBL] [Abstract][Full Text] [Related]
17. Leukaemia-derived dendritic cells can be generated from blood or bone marrow cells from patients with myelodysplasia: a methodological approach under serum-free culture conditions.
Kufner S; Zitzelsberger H; Kroell T; Pelka-Fleischer R; Salem A; de Valle F; Schmid C; Schweiger C; Kolb HJ; Schmetzer HM
Scand J Immunol; 2005 Jul; 62(1):75-85. PubMed ID: 16091127
[TBL] [Abstract][Full Text] [Related]
18. Paramunity-inducing Factors (PINDs) in dendritic cell (DC) cultures lead to impaired antileukemic functionality of DC-stimulated T-cells.
Ansprenger C; Vogt V; Schick J; Hirn-Lopez A; Vokac Y; Harabacz I; Braeu M; Kroell T; Karenberg A; Kolb HJ; Schmetzer H
Cell Immunol; 2018 Jun; 328():33-48. PubMed ID: 29580554
[TBL] [Abstract][Full Text] [Related]
19. Various 'dendritic cell antigens' are already expressed on uncultured blasts in acute myeloid leukemia and myelodysplastic syndromes.
Dreyssig J; Kremser A; Liepert A; Grabrucker C; Freudenreich M; Schmid C; Kroell T; Scholl N; Tischer J; Kufner S; Salih H; Kolb HJ; Schmetzer HM
Immunotherapy; 2011 Sep; 3(9):1113-24. PubMed ID: 21913833
[TBL] [Abstract][Full Text] [Related]
20. Interferon Gamma Secretion of Adaptive and Innate Immune Cells as a Parameter to Describe Leukaemia-Derived Dendritic-Cell-Mediated Immune Responses in Acute Myeloid Leukaemia in vitro.
Klauer LK; Schutti O; Ugur S; Doraneh-Gard F; Amberger DC; Rogers N; Krämer D; Rank A; Schmid C; Eiz-Vesper B; Schmetzer HM
Transfus Med Hemother; 2022 Feb; 49(1):44-61. PubMed ID: 35221867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
